Deruxtecan

Product Name: Deruxtecan
CAS No.: 1599440-13-7
Chemical Name: Deruxtecan
Synonyms: Deruxtecan;MC-GGFG-Exetecan;Deruxtecan analog;Deruxtecan（DX-8951）;Ibandronate Impurity 32;MC-GGFG-Exetecan Deruxtecan analog;Drug-Linker Conjugates for ADC,Inhibitor,inhibit,Deruxtecan;Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl]-;N-[(S)-10-Benzyl-1-[[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-1,2,3,9,10,12,13,15-octahydrobenzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide;N-[(S)-10-Benzyl-1-[[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-1,2,3,9,10,12,13,15-octahydrobenzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
CBNumber: CB24796642
Molecular Formula: C52H56FN9O13
Formula Weight: 1034.05
MOL File: 1599440-13-7.mol

More

Less

Deruxtecan Property

Boiling point:: 1491.1±65.0 °C(Predicted)
Density: 1.48±0.1 g/cm3(Predicted)
solubility: DMSO:67.5(Max Conc. mg/mL);65.28(Max Conc. mM)
pka: 11.18±0.40(Predicted)
form: Solid
color: White to yellow
InChI: InChI=1S/C52H56FN9O13/c1-3-52(73)33-19-38-48-31(23-62(38)49(70)32(33)25-75-51(52)72)47-35(14-13-30-28(2)34(53)20-36(59-48)46(30)47)57-43(67)26-74-27-60(24-39(54)63)50(71)37(18-29-10-6-4-7-11-29)58-42(66)22-56-41(65)21-55-40(64)12-8-5-9-17-61-44(68)15-16-45(61)69/h4,6-7,10-11,15-16,19-20,35,37,73H,3,5,8-9,12-14,17-18,21-27H2,1-2H3,(H2,54,63)(H,55,64)(H,56,65)(H,57,67)(H,58,66)/t35-,37-,52-/m0/s1
InChIKey: XSLGWYQNBQGZTG-MCZRLCSDSA-N
SMILES: C(N)(=O)CN(C(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN1C(=O)C=CC1=O)COCC(N[C@@H]1C2C3C(N=C4C5N(C(=O)C6COC(=O)[C@@](CC)(O)C=6C=5)CC4=2)=CC(F)=C(C)C=3CC1)=O

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

ChemScene

Product number: CS-0045125
Product name: Deruxtecan
Purity: 99.43%
Packaging: 1mg
Price: $750
Updated: 2021/12/16

ChemScene

Product number: CS-0045125
Product name: Deruxtecan
Purity: 99.43%
Packaging: 5mg
Price: $1500
Updated: 2021/12/16

ChemScene

Product number: CS-0045125
Product name: Deruxtecan
Purity: 99.43%
Packaging: 10mg
Price: $1950
Updated: 2021/12/16

More

Less

Deruxtecan Chemical Properties,Usage,Production

Uses

Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.

Indications

By Deruxtecan Preparation Trastuzumab deruxtecan drug is approved by the FDA for the treatment of patients with any HER2-positive advanced solid tumour (e.g., breast, gastric, and GOJ adenocarcinomas) and only after the patient has previously received other advanced treatments.

Mechanism of action

Deruxtecan is attached to the antibody by a peptide linker. After trastuzumab deruxtecan binds to HER2 found on malignant cells, it is internalized and linker cleavage occurs through the actions of lysosomal enzymes. After it is released through cleavage, DXd causes targeted DNA damage and apoptosis in cancer cells, due to the ability to cross cell membranes.

Side effects

The most common side effects of Deruxtecan (Trastuzumab deruxtecan) include: nausea, vomiting, diarrhoea, fatigue, hair loss, increased risk of infections (low white blood cell counts, red blood cell counts, and platelet counts), breathlessness, coughing, headache, bone or muscle pain, mouth ulcers, loss of appetite, weight loss, heart problems, liver or skin changes, low potassium levels. All of these side effects may not always occur at the same time and will vary from person to person. Serious adverse reactions include: interstitial lung disease/pneumonia, serious impairment of heart function and allergic reactions. Special care should be taken to contact your doctor in case of any serious adverse reactions.

Deruxtecan Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Deruxtecan Suppliers

China 106 United States 3 USA 1 Global 110

Shanghai Tekanbio Pharm-Tech Co., Ltd.

Tel: 021-50896099 18017206244
Fax: QQ：3268640975
Email: sales@tekanbio.com
Country: China
ProdList: 108
Advantage: 58

Anqing Runke Biomedical Technology Co., Ltd.

Tel: 0512-68716880 19984816880
Fax: 0556-5282330
Email: sales@growingchem.com
Country: China
ProdList: 306
Advantage: 58

ShangHai ChuanQian Chemcial Technique Centre

Tel: 15869524721
Email: 3525679403@qq.com
Country: China
ProdList: 4322
Advantage: 58

Changzhou Chenhong Biotechnology Co., Ltd.

Tel: 0519-85788828 13775037613
Email: sales@chemrenpharm.com
Country: China
ProdList: 3600
Advantage: 58

Levena (Suzhou) Biopharma Co., Ltd.

Tel: 0512-81877925 051281877925
Email: info@levena.cn
Country: China
ProdList: 48
Advantage: 58

YJ Pharma

Tel: 13962794339 13962794339
Email: 3686954964@qq.com
Country: China
ProdList: 189
Advantage: 58

Chemvon Biotechnology Co., Ltd

Tel: 021-50790412
Fax: +86-21-50790419
Email: info@chemvon.com
Country: China
ProdList: 371
Advantage: 57

Suzhou Zehou Biotechnology Co. , Ltd.

Tel: 0512-68716880 19984816880
Fax: 18075373931
Email: sales@growingchem.com
Country: China
ProdList: 194
Advantage: 64

ChemCell Biomedicine Co.,Ltd.

Tel: 020-13556033878 2965585218 13556033878
Fax: 0086-0757-85406358
Email: chemcell@hotmail.com
Country: China
ProdList: 369
Advantage: 52

Chengdu Pukang Biotechnology Co., Ltd

Tel: 028-82550498 19102685862
Fax: 086-28-82550468
Email: sales@pu-kang.com
Country: China
ProdList: 485
Advantage: 58

More

Less

View Lastest Price from Deruxtecan manufacturers

Henan Aochuang Chemical Co.,Ltd.

Product: Deruxtecan 1599440-13-7
Price: US $0.00-0.00/KG
Min. Order: 1KG
Purity: 98%
Supply Ability: 1Ton
Release date: 2022-10-13

1599440-13-7, DeruxtecanRelated Search:

Deruxtecan

Deruxtecan analog

Deruxtecan

Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl]-

MC-GGFG-Exetecan

Deruxtecan（DX-8951）

N-((S)-10-Benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide

Drug-Linker Conjugates for ADC,Inhibitor,inhibit,Deruxtecan

N-[(S)-10-Benzyl-1-[[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-1,2,3,9,10,12,13,15-octahydrobenzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide

MC-GGFG-Exetecan Deruxtecan analog

N-((S)-10-Benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide

N-[(S)-10-Benzyl-1-[[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-1,2,3,9,10,12,13,15-octahydrobenzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide

6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-{[({[(1S)-1-[({[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,1?.0?,13.0?,11.02?,2?]tetracosa-1,6(11),12,14,16(24),17,19-heptaen-23-yl]carbamoyl}methoxy)methyl]carbamoyl}methyl)carbamoyl]-2-phenylethyl]carbamoyl}methyl)carbamoyl]methyl}hexanamide

Ibandronate Impurity 32

1599440-13-7

C52H56FN9O13

Pharmaceutical

API

ADC